The Munich based surgical robotic startup medineering has announced the successful closing of the Series-A-Round. The investment of medineering’ s new strategic partner Brainlab will enable the startup continuing its way to become a global surgical robotic manufacturer, company pronounced. Specifically, the investment will be used for the commercialization of the first robot for endo- and transnasal surgery.
Great feedback from first prototypes
“We started the development of our modular platform in October 2014 consisting of an intelligent arm and application specific robotic hands, which can be exchanged depending on the surgical needs. We got a great feedback for the first prototypes of our robotic hand for endo- and transnasal surgery. This motivated us to open our platform also for third-party robotic hands and instruments, depending on the dedicated surgical tasks,” said Stephan Nowatschin, CEO and co-founder of medineering.
Medineering develops, manufactures and markets a modular robotic portfolio, establishing new ways in minimally invasive surgery. The portfolio consists of an intelligent holding arm and small application specific robotic hands assisting surgeons in anatomically complex working spaces. The first robotic hand will be an endoscope guidance system for endo- and transnasal surgery. medineering was founded in June 2014 by Dr. Maximilian Krinninger and Dr. Stephan Nowatschin.
Surgical needs of robotic assistance in the OR
“The promising approach of medineering addresses reasonably the surgical needs of robotic assistance in the OR“, said Rainer Birkenbach, Executive Vice President at Brainlab. “Soon we will present the first robot for endo- and transnasal approaches supporting surgeons facing anatomically complex working spaces with robotic assistance“, added Maximilian Krinninger, CTO and cofounder of medineering.